Evidence map›Paper›PMID 31324766›Full record

SynthesisNature communications2019

ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response.

Adebowale A Adeyemo, Norann A Zaghloul, Guanjie Chen, Ayo P Doumatey, Carmen C Leitch, Timothy L Hostelley, Jessica E Nesmith, Jie Zhou, Amy R Bentley, Daniel Shriner and 17 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 3 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 3 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. The Zinc Finger Ran-Binding Protein 3 (ZRANB3): An Advanced Perspective.International journal of molecular sciences · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Phenotypic and Genetic Diversity in Diabetes Across Populations.The Journal of clinical endocrinology and metabolism · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Novel KCNQ2 missense variant expands the genotype spectrum of DEE7.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 5 countries.

Adebowale A AdeyemoCenter for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, 20892, MD, USA.ORCID http://orcid.org/0000-0002-3105-3231
Norann A ZaghloulDivision of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, 21201, MD, USA.
Guanjie ChenCenter for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, 20892, MD, USA.ORCID http://orcid.org/0000-0002-5745-5618
Ayo P DoumateyCenter for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Carmen C LeitchDivision of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, 21201, MD, USA.
Timothy L HostelleyDivision of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, 21201, MD, USA.
Jessica E NesmithDivision of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, 21201, MD, USA.
Jie ZhouCenter for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Amy R BentleyCenter for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, 20892, MD, USA.ORCID http://orcid.org/0000-0002-0827-9101
Daniel ShrinerCenter for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Olufemi FasanmadeUniversity of Lagos, Lagos, Nigeria.
Godfrey OkaforUniversity of Nigeria Teaching Hospital, Enugu, Nigeria.
Benjamin EghanUniversity of Science and Technology, Kumasi, Ghana.
Kofi Agyenim-BoatengUniversity of Science and Technology, Kumasi, Ghana.
Settara ChandrasekharappaNational Human Genome Research Institute, National Institutes of Health, Bethesda, 20892, MD, USA.
Jokotade AdeleyeCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
William BalogunCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Samuel OwusuUniversity of Ghana Medical School, Accra, Ghana.
Albert AmoahUniversity of Ghana Medical School, Accra, Ghana.
Joseph AcheampongUniversity of Science and Technology, Kumasi, Ghana.
Thomas JohnsonUniversity of Lagos, Lagos, Nigeria.
Johnnie OliUniversity of Nigeria Teaching Hospital, Enugu, Nigeria.
Clement AdebamowoDepartment of Epidemiology and Public Health; Institute of Human Virology; Greenebaum Comprehensive Cancer Center, School of Medicine, University of Maryland, Baltimore, 21201, MD, USA.
South Africa Zulu Type 2 Diabetes Case-Control Study
Francis CollinsNational Institutes of Health, Bethesda, 20892, MD, USA.
Georgia DunstonNational Human Genome Center at Howard University, Washington, 20059, DC, USA.
Charles N RotimiCenter for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, 20892, MD, USA. rotimic@mail.nih.gov.ORCID http://orcid.org/0000-0001-5759-053X
National Institutes of Health · USCentre for Human Genetics · GBUniversity of Cambridge · GBUniversity of Maryland, Baltimore · USKwame Nkrumah University of Science and Technology · GHUniversity of Ghana · GHUniversity of Ibadan · NGUniversity of Lagos · NGUniversity of Nigeria Teaching Hospital · NGNational Human Genome Research Institute · USWellcome Sanger Institute · GB

Funding

Genetic epidemiology of complex diseasesZIAHG200362 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ROTIMI, CHARLES · 2009 to 2025
$54.7M
Genetic analysis of type II diabetes in Finnish populationZIAHG000024 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ERDOS, MICHAEL · 2009 to 2025
$38.2M
Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RYAN, ALICE S. · 2005 to 2019
$17.3M
EXPAND PARTICIPATION BY MINORITIES IN BIOMEDICAL SCIENCER25GM055036 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI SUMMERS, MICHAEL FINLEY · 1996 to 2021
$16.9M
NHGRI/DIR Genomics CoreZICHG200346 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI CHANDRASEKHARAPPA, SETTARA · 2010 to 2025
$14.5M
Diabetes, Obesity, and Metabolic ComplicationsT32DK098107 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI TAYLOR, SIMEON I. · 2015 to 2025
$2.4M
Basal body regulation of glucose homeostasisR01DK102001 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D · 2014 to 2018
$1.7M
Interaction of exocrine and endocrine pancreas in obesity ciliopathiesF31DK115179 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI HOSTELLEY, TIMOTHY LAIN · 2018 to 2019
$66k
MINORITY INTERNATIONAL RESEARCH TRAINING GRANTT37TW000041 · FIC · HOWARD UNIVERSITY · PI ADAMS-CAMPBELL, LUCILE L · 1993 to 1998
–
FIC NIH HHS T37 TW000041Intramural NIH HHS ZIA HG200362NHGRI NIH HHS ZIA HG200362NIDDK NIH HHS F31 DK115179NIDDK NIH HHS P30 DK072488NIDDK NIH HHS R01 DK102001NIDDK NIH HHS T32 DK098107NIGMS NIH HHS R25 GM055036
6 · The paper itself

Abstract

Genome analysis of diverse human populations has contributed to the identification of novel genomic loci for diseases of major clinical and public health impact. Here, we report a genome-wide analysis of type 2 diabetes (T2D) in sub-Saharan Africans, an understudied ancestral group. We analyze ~18 million autosomal SNPs in 5,231 individuals from Nigeria, Ghana and Kenya. We identify a previously-unreported genome-wide significant locus: ZRANB3 (Zinc Finger RANBP2-Type Containing 3, lead SNP p = 2.831 × 10

Indexed as

Genetic Association StudiesAfrica, NorthernAnimalsApoptosisBase SequenceBlood GlucoseCRISPR-Cas SystemsDiabetes Mellitus, Type 2Disease Models, AnimalDNA HelicasesFemaleGene EditingGene Knockout TechniquesGenetic Predisposition to DiseaseGenotypeGhanaBlood GlucoseDNA HelicasesGlucoseInsulinRNA, Small InterferingTCF7L2 protein, humanTranscription Factor 7-Like 2 ProteinZRANB3 protein, human

Identifiers

PMID31324766
PMCPMC6642147
OpenAlexW2963506959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.